Suppr超能文献

风湿性疾病结局评估的最新进展。

Update on outcome assessment in rheumatic disorders.

作者信息

Molenaar E, van der Heijde D, Boers M

机构信息

Department of Rheumatology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.

出版信息

Curr Opin Rheumatol. 2000 Mar;12(2):91-8. doi: 10.1097/00002281-200003000-00002.

Abstract

Outcome assessment in rheumatic disorders is getting more and more attention. A series of Outcome Measures in Rheumatology (OMERACT) conferences has provided a good impulse for further research in the field. In this chapter we will review the results of the last OMERACT 4 conference in detail. This conference was focused on longitudinal/observational studies, rheumatoid arthritis (response criteria and imaging), and core sets for ankylosing spondylitis and systemic lupus erythematosus. Moreover, an overview of recent literature on measures of disease activity, quality of life measures, and imaging is presented. For the various rheumatic disorders, several new instruments and/or further validation steps are described.

摘要

风湿性疾病的疗效评估越来越受到关注。一系列风湿病疗效评估(OMERACT)会议为该领域的进一步研究提供了有力推动。在本章中,我们将详细回顾上一次OMERACT 4会议的成果。本次会议聚焦于纵向/观察性研究、类风湿关节炎(反应标准和影像学)以及强直性脊柱炎和系统性红斑狼疮的核心指标集。此外,还概述了近期关于疾病活动度测量、生活质量测量和影像学的文献。针对各种风湿性疾病,介绍了几种新的工具和/或进一步的验证步骤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验